Levi & Korsinsky, LLP announces that an NNOX class action lawsuit has been filed on behalf of investors who purchased Nano-X Imaging Ltd.(NNOX) securities between June 17, 2021, and August 18, 2021. For more on the NNOX Lawsuit please contact us today.

According to the Nano-X lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Nano-X’s 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC’s regulatory and commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE NNOX CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Nano-X you have until December 6, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com